Lisa Gill
Stock Analyst at JP Morgan
(3.46)
# 961
Out of 5,116 analysts
135
Total ratings
51.09%
Success rate
4.54%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $79.61 | +26.87% | 6 | Dec 17, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $23 | $18.78 | +22.47% | 6 | Dec 17, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $32 → $33 | $24.13 | +36.76% | 6 | Nov 13, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $6 → $5 | $2.75 | +81.82% | 2 | Nov 11, 2025 | |
| PGNY Progyny | Maintains: Neutral | $25 → $26 | $25.80 | +0.78% | 1 | Nov 11, 2025 | |
| COR Cencora | Maintains: Overweight | $344 → $417 | $341.05 | +22.27% | 3 | Nov 11, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $291 → $317 | $253.89 | +24.86% | 2 | Nov 7, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $428 → $375 | $276.51 | +35.62% | 14 | Nov 4, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $384 → $394 | $349.88 | +12.61% | 6 | Oct 28, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $310 → $425 | $331.83 | +28.08% | 10 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $821 → $853 | $828.26 | +2.99% | 14 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $8.62 | +16.01% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7 → $6 | $2.77 | +116.61% | 5 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $175.94 | +7.99% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $20.03 | +49.78% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $32.58 | +25.84% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $258.83 | -1.09% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $142 → $145 | $208.29 | -30.39% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $38.11 | -52.77% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $5.54 | -9.75% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $15.87 | +76.43% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $7.12 | +26.40% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $9.22 | +95.23% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $164.84 | +139.63% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $227.64 | -18.29% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $200.60 | -30.21% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $477.13 | -30.42% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.73 | +1,140.01% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.13 | +12.20% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $76.13 | +9.02% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $40.51 | +141.92% | 1 | Jan 6, 2023 |
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $79.61
Upside: +26.87%
Alignment Healthcare
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $18.78
Upside: +22.47%
Privia Health Group
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $24.13
Upside: +36.76%
GoodRx Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.75
Upside: +81.82%
Progyny
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $25.80
Upside: +0.78%
Cencora
Nov 11, 2025
Maintains: Overweight
Price Target: $344 → $417
Current: $341.05
Upside: +22.27%
Labcorp Holdings
Nov 7, 2025
Maintains: Overweight
Price Target: $291 → $317
Current: $253.89
Upside: +24.86%
The Cigna Group
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $276.51
Upside: +35.62%
Elevance Health
Oct 28, 2025
Maintains: Overweight
Price Target: $384 → $394
Current: $349.88
Upside: +12.61%
UnitedHealth Group
Oct 9, 2025
Maintains: Overweight
Price Target: $310 → $425
Current: $331.83
Upside: +28.08%
Sep 26, 2025
Maintains: Overweight
Price Target: $821 → $853
Current: $828.26
Upside: +2.99%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $8.62
Upside: +16.01%
Aug 27, 2025
Maintains: Underweight
Price Target: $7 → $6
Current: $2.77
Upside: +116.61%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $175.94
Upside: +7.99%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $20.03
Upside: +49.78%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $32.58
Upside: +25.84%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $258.83
Upside: -1.09%
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $208.29
Upside: -30.39%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $38.11
Upside: -52.77%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $5.54
Upside: -9.75%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $15.87
Upside: +76.43%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $7.12
Upside: +26.40%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $9.22
Upside: +95.23%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $164.84
Upside: +139.63%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $227.64
Upside: -18.29%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $200.60
Upside: -30.21%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $477.13
Upside: -30.42%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.73
Upside: +1,140.01%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.13
Upside: +12.20%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $76.13
Upside: +9.02%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $40.51
Upside: +141.92%